Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on February 24, 2017. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Verigene Test Kits

Awarded
N0025917N0047Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
DIBBS
CULTURE MEDIUM, THAYER-
Solicitation # SPE2DS-27-T-1066
Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 4 days
NAICS: 325413
New
Federal
6550--Optilite analyzer reagents
Solicitation # 36C26227Q0052
The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.
262-NETWORK Contract Office 22 (36C262)

POSTED

3 days ago

DEADLINE

in 5 days
NAICS: 325413
New
Federal
BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems
Solicitation # HT942627QE003
The Defense Health Agency is soliciting quotations to establish a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1 in Texas. To maintain FDA approval and satisfy research protocols, the contractor must provide original manufacturer-supplied consumables, including Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, ACD-A Solution, and 150 mL couplers. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS 325413. The resulting BPA will have a 60-month ordering period with a total ceiling of 35 million dollars, though some documentation notes a lower limit of 350,000 dollars. Individual call orders are capped at 50,000 dollars, while Government Purchase Card orders are limited to 15,000 dollars. Awards will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as pass or fail. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. Quotations are due by November 6, 2026, and must be submitted in two separate volumes covering technical capability and pricing.
Army Medical Resources Acq Activity

POSTED

7 days ago

DEADLINE

in 7 days
NAICS: 325413
Federal
6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ
Solicitation # 36C24527Q0042
The Department of Veterans Affairs, specifically the VA North Atlantic Health Network (HSA 1.3), is soliciting a firm-fixed-price, Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Cepheid GeneXpert testing supplies. This requirement covers the procurement of FDA-approved reagents, consumables, and service for PCR analyzers to detect various pathogens, including CoV-2, Influenza, RSV, MRSA, and Mycobacterium Tuberculosis. The contract is structured with a base period ending October 31, 2027, and three subsequent one-year option periods extending through October 31, 2030. Deliveries will be made to multiple VA Medical Centers across Maryland, West Virginia, and Washington DC. This acquisition is set aside for HUBZone small businesses. Award will be determined using the Lowest Price Technically Acceptable (LPTA) method, evaluating technical acceptability, delivery performance, past performance, and price, with additional credit given to certified SDVOSB or VOSB offerors. Key contractor requirements include being an authorized distributor, acknowledging orders within 24 hours, and guaranteeing a minimum four-month expiration date on reagents. Additionally, the vendor must provide an emergency plan to deliver replacement supplies within 24 hours if products are found to be defective. Invoices must be submitted electronically, and payments will be processed in accordance with the Prompt Payment Act.
245-NETWORK Contract Office 5 (36C245)

POSTED

8 days ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The Naval Medical Center San Diego intends to award a sole source purchase order to Nanosphere, Inc. for assays and consumables compatible with the existing Verigene system. This procurement is necessary for the multiplex detection of various respiratory viruses, including Influenza A and B, RSV, and Bordetella pertussis, as well as the identification of bacteria in positive blood cultures. The requirement specifies the use of Verigene RP Flex Test Cartridges, Extraction Trays, and Amplification Trays to ensure high throughput, accuracy, and system compatibility. The decision to sole source is based on proprietary rights and warranty provisions, as using unauthorized assays could damage the analyzer or produce inaccurate results. The contract falls under NAICS code 325413 with a delivery date of March 2, 2017. While the government intends to proceed with Nanosphere, Inc., interested parties were invited to submit capability statements by February 24, 2017, to demonstrate their ability to meet the technical and cost requirements.

General Info

Contract Value

$102,400

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

CA, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Combined Synopsis

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Naval Medical Center San Diego Ca
Contacts1 person available
OfficeSAN DIEGO, CA, 92134-5000, USA
Office AddressSAN DIEGO, CA, 92134-5000, USA

Full Description

Show more
Notice of Intent to Sole Source The Naval Medical Center San Diego (NMCSD) intends to award a sole source purchase order under the authority of FAR 13.106-1(b) (1) (i), due to only one source being available to meet the Government's needs, to Nanosphere, Inc. 4088 Commercial Ave Northbrook, IL, 60062-1829 The Naval Medical Center San Diego has a requirement for a purchase order for assays and consumables to be used for multiplex detection of respiratory viruses. The assays and consumables shall be compatible with the Nanosphere Verigene system that NMC San Diego currently owns. These essays shall be able to be used to perform multiple tests on an individual patient specimen simultaneously in a fully-automated random-access capacity that allows for an increased throughput while decreasing the demands on staff workload. The use of nucleic acid amplification and multiplex detection increased accuracy and precision not provided by other testing methodologies. These essays shall be able to detect viruses from swabs, aspirates and washes as well as sputum to detect at a minimum Influenza A, Influenza A subtypes H1 and H3, Influenza B, Respiratory Syncytial Virus, Adenovirus, Rhinovirus, Parainfluenza Viruses 1, 2, 3, and 4, Metapneumovirus and Bordetella pertussis. Specificity and differentiation of target detection is essential to aboid cross-reactivity and false reporting of results with a demonstrated specificity of at least 95% for each individual target included in the panel. Assay sensitivity should be sufficient to detect a range of viral titers that corresponds to very early infection, fulminant infection, and convalescing infections. Also provide testing for the identification of gram-positive and gram-negative bacteria in positive blood cultures. The following items are needed: Clin # Catalog Number Description Qty 0001 20-005-024 Verigene RP Flex Test Cartridges and Extraction Trays, 20/kit 45 0002 20-012-024 Verigene RP Flex Amplification Trays, 20/kit 45 0003 Shipping 0004-Option quantity 20-005-024 Verigene RP Flex Test Cartridges and Extraction Trays, 20/kit 45 0005-Option quantity 20-012-024 Verigene RP Flex Amplification Trays, 20/kit 45 0006-Option quantity-Shipping The objective of this sole source award is to procure Verigene RP Flex Test for the existing Nanosphere Verigene System. Due to warranty provisions and to avoid potential damage to the analyzer (and test results), only Verigene Test Kit from Nanosphere Inc. are to be used. Sole source is based on proprietary reasons in that Nanosphere Inc. is a sole proprietor of the Verigene test, the use of an unauthorized source for the assay may cause malfunction or damage to the Nanosphere system or cause inaccurate testing results. Due to the proprietary nature of this supplies, no other company was found that could provide the assay should a problem arise. Delivery Day: March 2, 2017 The NAICS code for this requirement is 325413; the small business size standard is 1,250. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 7 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 10:00 AM Local Time, 24 February, 2017. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: contact@example.gov. The email subject line shall state: "Naval Medical Center San Diego, Notice of Intent to Award Sole Source for Verigene Test Kits" NO TELEPHONE REQUESTS WILL BE HONORED

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS